Article
CD55 polymorphisms and risk of aspirin‑exacerbated respiratory disease.
Molecular medicine reports - 1 Nov 2012
Lee Jin Sol, Bae Joon Seol, Kim Jeong-Hyun, Kim Jason Yongha, Park Tae Joon, Pasaje Charisse Flerida, Park Byung-Lae, Cheong Hyun Sub, Uh Soo-Taek, Jang An-Soo, Choi Inseon S, Park Choon-Sik, Shin Hyoung Doo
Abstract excerpt
Aspirin-exacerbated respiratory disease (AERD) is a respiratory disease characterized by acute bronchial responses upon the administration of non-steroidal anti‑inflammatory drugs (NSAIDs) and the immune response by mast cells is regarded as one of the noteworthy causes of AERD pathogenesis. The complement cascade is regarded as a key mechanism for clearing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
